Growing community of inventors

Bengaluru, India

Vyjayanthi N Kambam

Average Co-Inventor Count = 12.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Vyjayanthi N KambamNeville J Anthony (1 patent)Vyjayanthi N KambamKenneth Jay Barr (1 patent)Vyjayanthi N KambamRaman Kumar Bakshi (1 patent)Vyjayanthi N KambamChristopher Francis Thompson (1 patent)Vyjayanthi N KambamMark E Scott (1 patent)Vyjayanthi N KambamCarolyn Michele Cammarano (1 patent)Vyjayanthi N KambamJayanth Thiruvellore Thatai (1 patent)Vyjayanthi N KambamSubhendu Kumar Mohanty (1 patent)Vyjayanthi N KambamChandra Sekhar Korapala (1 patent)Vyjayanthi N KambamPrashant R Latthe (1 patent)Vyjayanthi N KambamSujit Kumar Sarkar (1 patent)Vyjayanthi N KambamRaman Kumar Bakshi (0 patent)Vyjayanthi N KambamCarolyn Michelle Cammarano (0 patent)Vyjayanthi N KambamMark E Scott (0 patent)Vyjayanthi N KambamVyjayanthi N Kambam (1 patent)Neville J AnthonyNeville J Anthony (69 patents)Kenneth Jay BarrKenneth Jay Barr (44 patents)Raman Kumar BakshiRaman Kumar Bakshi (26 patents)Christopher Francis ThompsonChristopher Francis Thompson (22 patents)Mark E ScottMark E Scott (19 patents)Carolyn Michele CammaranoCarolyn Michele Cammarano (4 patents)Jayanth Thiruvellore ThataiJayanth Thiruvellore Thatai (2 patents)Subhendu Kumar MohantySubhendu Kumar Mohanty (1 patent)Chandra Sekhar KorapalaChandra Sekhar Korapala (1 patent)Prashant R LatthePrashant R Latthe (1 patent)Sujit Kumar SarkarSujit Kumar Sarkar (1 patent)Raman Kumar BakshiRaman Kumar Bakshi (0 patent)Carolyn Michelle CammaranoCarolyn Michelle Cammarano (0 patent)Mark E ScottMark E Scott (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merck Sharp + Dohme Corp. (1 from 2,405 patents)


1 patent:

1. 9486448 - Pyrrolidine derived beta 3 adrenergic receptor agonists

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/9/2026
Loading…